PlainRecalls
FDA Drug Low Class III Terminated

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Reported: August 22, 2018 Initiated: August 9, 2018 #D-1099-2018

Product Description

Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.

Reason for Recall

Defective Container: Customer complaints of punctures in the bottle.

Details

Units Affected
95,296 bottles
Distribution
Nationwide in the USA
Location
La Jolla, CA

Frequently Asked Questions

What product was recalled?
Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90 mg, 120-count bottle, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99.. Recalled by Orexigen Therapeutics, Inc.. Units affected: 95,296 bottles.
Why was this product recalled?
Defective Container: Customer complaints of punctures in the bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 22, 2018. Severity: Low. Recall number: D-1099-2018.